Source - SMW
FastForward Innovations has announced that Intensity Therapeutics has been granted a US patent.

 FastForward has a 2.118% stake in the biotechnology company which is developing proprietary cancer immunotherapy products.

FastForward  also said that Intensity also noted that the Australian Patent and Trademark Office also intended to grant it a patent.